Followers | 504 |
Posts | 10140 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Sunday, December 06, 2015 1:43:16 PM
bullish 100.28
falling wedge breakout
bullish engulfing candle
## source: finance.yahoo.com
Sat, 05 Dec 2015 18:17:33 GMT ~ Is Ultragenyx Pharmaceutical Inc (RARE) Going to Burn These Hedge Funds?
read full: http://www.insidermonkey.com/blog/is-ultragenyx-pharmaceutical-inc-rare-going-to-burn-these-hedge-funds-397331/
*********************************************************
Thu, 03 Dec 2015 13:30:00 GMT ~ Ultragenyx Announces First Patient Enrolled in Global Phase 3 Study of KRN23 in Adults With X-Linked Hypophosphatemia (XLH)
[GlobeNewswire] - NOVATO, Calif., Dec. 03, 2015-- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced the initiation ...
read full: http://finance.yahoo.com/news/ultragenyx-announces-first-patient-enrolled-133000975.html
*********************************************************
Wed, 02 Dec 2015 21:30:00 GMT ~ Ultragenyx to Present at the Oppenheimer Annual Healthcare Conference
[GlobeNewswire] - NOVATO, Calif., Dec. 02, 2015-- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced that Emil D. Kakkis, ...
read full: http://finance.yahoo.com/news/ultragenyx-present-oppenheimer-annual-healthcare-213000446.html
*********************************************************
Wed, 02 Dec 2015 13:30:00 GMT ~ Ultragenyx Reports Positive Interim 40-Week Data From Pediatric Phase 2 Study of KRN23 in X-Linked Hypophosphatemia
[GlobeNewswire] - NOVATO, Calif., Dec. 02, 2015-- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced positive interim ...
read full: http://finance.yahoo.com/news/ultragenyx-reports-positive-interim-40-133000458.html
*********************************************************
Wed, 18 Nov 2015 18:04:24 GMT ~ ULTRAGENYX PHARMACEUTICAL INC. Financials
read full: http://finance.yahoo.com/q/is?s=rare
*********************************************************
$RARE charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$RARE company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/RARE/company-info
Ticker: $RARE
OTC Market Place: Not Available
CIK code: not found
Company name: Ultragenyx Pharmaceutical Inc.
Incorporated In:
$RARE share structure
## source: otcmarkets.com
Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available
$RARE extra dd links
Company name: Ultragenyx Pharmaceutical Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/RARE/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/RARE/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=RARE+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=RARE+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=RARE+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/RARE/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/RARE/news - http://finance.yahoo.com/q/h?s=RARE+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/RARE/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/RARE/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/RARE/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/RARE/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/RARE/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/RARE/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/RARE/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/RARE/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=RARE+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/RARE
DTCC (dtcc.com): http://search2.dtcc.com/?q=Ultragenyx+Pharmaceutical+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Ultragenyx+Pharmaceutical+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Ultragenyx+Pharmaceutical+Inc.&x=0&y=0
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/RARE/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/RARE
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/RARE/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/RARE/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/RARE/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/RARE/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/RARE/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/RARE/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/RARE/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=RARE&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=RARE
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/RARE/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=RARE+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=RARE+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=RARE
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=RARE
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=RARE+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/RARE/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=RARE+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/RARE.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=RARE
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/RARE/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/RARE/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/RARE/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/RARE/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/RARE
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/RARE
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/RARE:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=RARE
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=RARE
$RARE DD Notes ~ http://www.ddnotesmaker.com/RARE
Recent RARE News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/18/2024 05:03:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2024 03:50:56 PM
- Ultragenyx to Participate in Investor Conferences in September • GlobeNewswire Inc. • 08/29/2024 08:30:00 PM
- Tactical Resources, a Growing North American Rare Earth Elements Company, to List on NASDAQ • Business Wire • 08/23/2024 11:00:00 AM
- Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 08/21/2024 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 08:07:27 PM
- Ultragenyx Reports Second Quarter 2024 Financial Results and Corporate Update • GlobeNewswire Inc. • 08/01/2024 08:05:39 PM
- Ultragenyx to Host Conference Call for Second Quarter 2024 Financial Results and Corporate Update • GlobeNewswire Inc. • 07/25/2024 08:05:00 PM
- Ultragenyx to Present GTX-102 Angelman Syndrome Program Update at the ASF Family Conference and Research Symposium • GlobeNewswire Inc. • 07/24/2024 12:00:00 PM
- Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 07/19/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2024 08:06:21 PM
- Ultragenyx Announces Successful End-of-Phase 2 Meeting with FDA for GTX-102 Angelman Syndrome Program • GlobeNewswire Inc. • 07/17/2024 08:05:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 07/12/2024 08:04:05 PM
- Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 06/20/2024 08:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/20/2024 06:23:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/20/2024 06:22:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/20/2024 06:22:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/17/2024 10:31:31 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 06/14/2024 09:11:24 PM
- Ultragenyx Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants • GlobeNewswire Inc. • 06/14/2024 12:49:09 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/12/2024 11:47:14 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 06/12/2024 09:20:06 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/12/2024 09:10:24 PM
- Ultragenyx Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants • GlobeNewswire Inc. • 06/12/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/12/2024 08:04:10 PM
FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM